ASH 2026 guideline on severe and very severe acquired aplastic anaemia: 33 recommendations and 4 good practice statements, mostly on low or very low certainty evidence, prioritising HCT for younger patients with a matched donor and adding eltrombopag to immunosuppression.
Guideline
Scheinberg et al. American Society of Hematology 2026 guidelines for the diagnosis and management of severe and very severe acquired aplastic anemia